scPharmaceuticals Inc. (SCPH) Tops Q4 EPS by 3c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q4 EPS of ($0.35), $0.03 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $12.15 million versus the consensus estimate of $12.13 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• U.S. presses Meta to agree to A.I. reviews as security concerns rise - NYT
• Cboe launches binary options suite tied to Mini-S&P 500 Index